With over a century of discovery and translational research in infectious diseases, the University of Liverpool is a recognised leader in this field.
Our work covers both global health problems plus national and local issues. The depth and breadth of our clinical expertise in infectious diseases, capability in translational science and facilities for undertaking preclinical work and clinical trials exemplify the Liverpool Advantage in this field of research.
Our interdisciplinary approach seamlessly brings together medical and veterinary science with a focus on emerging infectious diseases and zoonoses (diseases that spread from animals to humans).
As a pioneer in infection and global health, the University is in a prime position to respond when new global threats emerge, such as the recent Ebola crisis and Zika epidemic.
Combatting and preventing antimicrobial resistance is a core theme across our work, and Liverpool operates at all scales from viruses, through to multicellular parasites, in animals, humans and in the environment.
The scope of our infection pharmacology expertise is distinct, covering formulation, improved dosing, repurposing drugs, PK/PD, drug interactions, toxicology, as well as designing novel drug delivery mechanisms.
Maximising the Impact of Rotavirus Vaccination
For over 20 years, the University of Liverpool has led a global programme of research to support the widespread introduction of rotavirus vaccines and maximise impact.
Fighting the Zika virus
The Institute of Infection and Global Health is among the leading research and public health organisations which gathered in Brazil for the launch of ZikaPLAN (Zika Preparedness Latin American Network).
Centre for Global Vaccine Research
The Centre for Global Vaccine Research is an interdisciplinary research initiative, reaching across the Faculty of Health and Life Sciences with partners around the world.
The Liverpool Advantage - partnerships
NIHR Health Protection Units
From bench to bedside
Our close partnerships with Liverpool School of Tropical Medicine, Royal Liverpool University Hospital and Alder Hey Children's Hospital give us a distinct advantage in this field.
The Centre of Excellence in Infectious Diseases Research develops innovative technologies for prevention, control and treatment of infectious diseases.
Meet some of our leading academics in infectious diseases research:
Head of the Brain Infections Group; Professor of Neurological Science
Dean of the Institute of Infection and Global Health
Senior Lecturer, Clinical Infection, Microbiology and Immunology
Professor, Clinical Infection, Microbiology and Immunology
Professor of Therapeutics and Infectious Diseases
Professor of Public Health and Policy
Oxenhale Chair of Veterinary Epidemiology
Professor of Bacterial Pathogenesis
Professor of Infectious Diseases and Global Health,
Honorary Consultant Royal Liverpool & Broadgreen University Hospitals Trust
Professor, Molecular and Clinical Pharmacology
Reader in Epidemiology
Professor, Veterinary Parasitology
Find out more about our research into infectious diseases:
- Institute of Veterinary Science
- Centre for Global Vaccine Research
- Antimicrobial Pharmacodynamics and Therapeutics
- Wellcome Trust Centre for Global Health Research
- Dynamics and Management of Host Microbe Interactions
- Institute of Infection and Global Health
- NIHR Health Protection Research Unit in Emerging and Zoonotic Infections
- NIHR Health Protection Research Unit in Gastrointestinal Infections